75. Yogesh Mahadu Khetmalis, Guruvelli Padma Vijaya Sangeetha, Ala Chandu, Swati, Sankaranarayanan Murugesan, Vivek Sharma, Muthyala Murali Krishna Kumar, Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis, and Biological Evaluation of Novel Oxindole Analogs as Anti-Tubercular Agents. Future Medicinal Chemistry 2023 (accepted).
74. Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Boddupalli Venkata Siva kumar, Ala Chandu, Banoth Karan Kumar, Gauri Shetye, Rui Ma, Sankaranarayanan Murugesan, Scott G. Franzblau, Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis and Biological Evaluation of Phenanthridine Amide and 1,2,3-Triazole Analogues against Mycobacterium tuberculosis. RSC Medicinal Chemistry, 2023 (accepted manuscript: DOI: 10.1039/D3MD00115F).
73. Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Guruvelli Padma Vijaya Sangeetha, Ala Chandu, Swati, Muthyala Murali Krishna Kumar, Vivek Sharma, Sankaranarayanan Murugesan, and Kondapalli Venkata Gowri Chandra Sekhar*, Tetrahydroisoquinoline based 5-Nitro-2-furoic acid Derivatives: A Promising New Approach for Anti-Tubercular Agents, New Journal of Chemistry, 2023 (in press).
72. Yogesh Mahadu Khetmalis, Ashna Fathima, Markus Schweipert, Cécile Debarnot, Naga Venkata Madhusudhan Rao Bandaru, Sankaranarayanan Murugesan, Trinath Jamma, Franz-Josef Meyer-Almes and Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis, and Biological Evaluation of Novel Quinazolin-4(3H)-One-Based Histone Deacetylase 6 (HDAC6) Inhibitors for Anticancer Activity, International Journal of Molecular Sciences 2023, 24 (13), 11044.
71. M. Abirami, Banoth Karan Kumar, Faheem, Sanchita Dey, Samridhi Johri, Rosa M. Reguera, Rafael Bala˜na-Fouce, Kondapalli Venkata Gowri Chandra Sekhar, Murugesan Sankaranarayanan, Molecular-level strategic goals and repressors in Leishmaniasis – Integrated data to accelerate target-based heterocyclic scaffolds, European Journal of Medicinal Chemistry, 2023, 257, 115471.
70. Savita, Adinarayana Nandikolla, Adarash Kumar Shukla, Kondapalli Venkata Gowri Chandra Sekhar and Anupam Bhattacharya, Visible light sensing of ions by a cynoquinoxaline 1,4-dioxide-based probe and its applications. Dalton Transactions, 2023, 52, 4103.
69. Yogesh Mahadu Khetmalis, Bakhya Shree, Boddupalli Venkata Siva Kumar, Markus Schweipert, Cécile Debarnot, Fathima Ashna, Murugesan Sankaranarayanan, Jamma Trinath, Vivek Sharma, Franz-Josef Meyer-Almes, Kondapalli Venkata Gowri Chandra Sekhar*, Design, synthesis, and biological evaluation of tetrahydroisoquinoline based hydroxamate derivatives as HDAC 6 inhibitors for cancer therapy. Journal of Molecular Structure, 2023, 1278, 134952.
68. Bodupalli Venkata Siva Kumar, Yogesh Mahadu Khetmalis, Adinarayana Nandikolla, Banoth Karan Kumar, Kevin Van Calster, Sankaranarayanan Murugesan, Davie Cappoen, and Kondapalli Venkata Gowri Chandra Sekhar*, Design, Synthesis, and Antimycobacterial Evaluation of Novel Tetrahydroisoquinoline Hydrazide Analogs, Chemistry & Biodiversity 2023, 20, e202200939.
67. Samridhi Johri, Banoth Karan Kumar, Sanchita Dey, Faheem, Rafael Balana-Fouce, Kondapalli Venkata Gowri Chandra Sekhar*, Selvaraj Kunjiappan, Sankaranarayanan Murugesan, Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor – An in-silico analysis. Journal of Molecular Graphics and Modelling 2023, 119, 108397.
66. Snehal Rajkumar Jadhav, Banoth Karan Kumar, Renuka Parshuram Joshi, Chougule Kishor Suryakant, Ala Chandu, Mohammed Muzaffar-Ur-Rehman, Yogesh Mahadu Khetmalis, Adinarayana Nandikolla, Sankaranarayan Murugesan and Kondapalli Venkata Gowri Chandra Sekhar*, Retrospective Review of Chromane Analogues as Anti-Protozoal Leads: A Decade's Worth of Evolution. Current Topics in Medicinal Chemistry, 2023, 23 (9), 713-735.
65. Ravi Kiran Panchakarla, Punna Rao Ravi, Manidhar Syam Kumar Buddha, Sumanth Mullangi, and Kondapalli Venkata Gowri Chandra Sekhar*, In silico toxicity assessment and trace level quantification of two genotoxic impurities in silodosin using capillary gas chromatography, Journal of Analytical Science and Technology, 2023 (https://doi.org/10.1186/s40543-023-00378-1).
64. Surendar Chitti, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Kevin Van Calster, Boddupalli Venkata Siva Kumar, Banoth Karan Kumar, Sankaranarayanan Murugesan, Davie Cappoen, and Kondapalli Venkata Gowri Chandra Sekhar *, Design, Synthesis and Biological Evaluation of Novel Spiro-[chroman-2,4'-piperidin]-4-one Analogues as Anti-Tubercular Agents. Chemistry & Biodiversity 2022, e202200304.
63. Surendar Chitti, Kevin Van Calster, Davie Cappoen, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Paul Cos, Banoth Karan Kumar, Sankaranarayanan Murugesan and Kondapalli Venkata Gowri Chandra Sekhar* Design, synthesis and biological evaluation of benzo-[d]-imidazo-[2,1-b]-thiazole and imidazo-[2,1-b]-thiazole carboxamide triazole derivatives as antimycobacterial agents. RSC Advances 2022, 12, 22385–22401.
62. Adinarayana, N., Yogesh, M. K., Mahalakshmi Naidu, K., Karan Kumar, B., Murugesan, S.,Chandra Sekhar, K.V.G.* Discovery of potent antitubercular agents: Design, synthesis and biological evaluation of 4-(3-(4-substitute dpiperazin-1-yl)-quinoxalin-2-yl)-naphthalen-1-ol analogues. Toxicol. in Vitro 82 (2022) 105370.
61. Adinarayana, N., Srinivasarao, S., Karan Kumar, B., Murugesan, S., Aggarwal, H., Balaña-Fouce, R., Melcón-Fernandez., Chandra Sekhar, K.V.G*. Design, synthesis and evaluation of novel phenanthridine triazole analogs as potential antileishmanial agents. Future Med. Chem. 2022, 14 (12), 867-880.
60.Faheem, Sanchita, D., Samridhi, J., M. Abirami, Karan Kumar, B., Donatella, T., Nicoletta, B., Rafael B. F., Murugesan, S., Chandra Sekhar, K.V.G., Search for structurally diverse heterocyclic analogs as dual-acting antimalarial and antileishmanial agents: An overview. Eur. J. Med. Chem. Reports. 2022, 4, 100031.
59. Yogesh, M, K., Surendar, C., Anjani, U. W., Karan Kumar, B., Murali Krishna Kumar M., Murugesan, S., Chandra Sekhar, K.V.G*. Design, Synthesis and Anti-mycobacterial Evaluation of Imidazo-[1,2-a]-pyridine Analogues. RSC Med. Chem. 2022, 13, 327-342.
58. Archana, B., N.V.M. Rao, B., Raghurami Reddy, B., Suraj, T.G., Subhendu, M., Wesley Roy, B., Sumanth Kumar V., Krishna Satya Alapati, Chandra Sekhar, K.V.G., Kavitha, N., Chandrasekhar, A., Susanta, Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders. Bioorg. Med. Chem. Lett. 2022, 55, 128448.
57. Surendar, C., Sravani, P., Adinarayana, N., Tarun Kumar, P., Karan Kumar, B., Murugesan, S., Balaram, G., Chandra Sekhar, K.V.G*. Design, Synthesis and SAR Studies of Novel Spirochromanone hydrochloride Analogues as Anticancer Agents. Future Med. Chem. 2022, 22 (5), 325-342.
56. Karan Kumar, B., Faheem., Rafael B. F., Estela M. F., Yolanda, Rosa M. R., Adinarayana, N., Chandra Sekhar, K.V.G., Murugesan, S. Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents. J. Biomol. Struct. Dyn. 2021, DOI: 10.1080/07391102.2021.1973564.
55. Nandikolla, A., Srinivasarao, S., Kumar, B.K., Murugesan, S., Aggarwal, H., Balaña-Fouce, R., Melcón-Fernandez, E., Pérez-Pertejo, Y., Chandra Sekhar, K.V.G*. Novel phenanthridine amide analogs as potential anti-leishmanial agents: In vitro and in silico insights. Bioorg. Chem., 2021, 117, 105414.
54. Faheem., Karan Kumar, B., Chandra Sekhar, K.V.G., Subhash Chander, Selvaraj, K., Murugesan, S. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. Expert Opin. Drug Discov., 2021, 16(10), 1119-114.
53. Ravi Kiran P., Punna Rao, R., Chandra Sekhar, K.V.G*. Liquid chromatography‑tandem mass spectrometric method for trace quantification of ethyl methanesulfonate: a genotoxic impurity in dapoxetine hydrochloride. Future J. Pharm. Sci. 2021, 7, 191.
52. Shivani, M., Adinarayana, N., Murugesan, S., Chandra Sekhar, K.V.G*. 1,8-Naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities. Future Med. Chem., 2021, 13(18), 1591-1618.
51. Yogesh, M, K., Shivani, M., Murugesan, S., Chandra Sekhar, K.V.G*. Oxindole and its derivatives: A review on recent progress in biological activities. Biomed. Pharmacother. 2021, 141, 111842.
50. Surendar, C., Sravani, P., Adinarayana, N., Tarun Kumar, P., Karan Kumar, B., Murugesan, S., Balaram, G., Chandra Sekhar, K.V.G*. Design, synthesis and biological evaluation of 7–(5–((substituted – amino)-methyl)-thiophen–2–yl)-spiro-[chroman–2,4′–piperidin]–4–one hydrochloride analogues as anticancer agents. Bioorg. Chem., 2021, 112, 104865.
49. Adinarayana, N., Srinivasarao, S., Yogesh, M.K., Karan Kumar, B., Murugesan, S., Gauri, S., Rui M., Scott, G. F., Chandra Sekhar, K.V.G*. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis. Toxicol. In Vitro, 2021, 74, 105137.
48. Faheem, Karan Kumar, B., Chandra Sekhar, K.V.G, Subhash, C., Selvaraj K, Murugesan, S.Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies. RSC Adv., 2021, 11, 12254–12287.
47. Karan Kumar, B., Faheem, Chandra Sekhar, K.V.G., Rupal O., Vijay Kumar P., Aravinda Pai, Murugesan, S., Pharmacophore based virtual screening, molecular docking, molecular dynamics and MMGBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. J. Biomol. Struct. Dyn. 2021, (in press – DOI: 0.1080/07391102.2020.1824814).
46. Ravi Kiran P, Punna Rao R, Chandra Sekhar, K.V.G*. Selective and Sensitive UHPLC Method for the Trace Analysis of Formaldehyde in Drug Substance Using Fused-core Column Technology and Detailed Pre-column Derivatization study. Curr. Pharm. Anal., 2021, 17, 201-209.
45. Faheem, Karan Kumar, B., Chandra Sekhar, K.V.G, Selvaraj K, Joazaizulfazli J, Rafael B, Murugesan, S. Recent update on the anti-infective potential of β-carboline analogs. Mini-Rev. Med. Chem. 2021, 21, 398 – 425.
44. Adinarayana, N., Srinivasarao, S., Karan Kumar, B., Murugesan, S., Himanshu A., Louise, L.M., Terry, K.S., Chandra Sekhar, K.V.G*. Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues. RSC Adv., 2020, 10, 38328-38343.
43. Suresh, A., Srinivasarao, S., Yogesh, M. K., Shashidhar, N., Murugesan, S., Chandra Sekhar, K.V.G*. Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis – a medicinal chemist perspective. RSC Adv., 2020, 10, 37098-37115.
42. Faheem, Karan Kumar, B., Chandra Sekhar, K.V.G., Selvaraj, K., Joazaizulfazli, J., Rafael, B. F., Babu, L.T., Murugesan, S. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. Bioorg. Chem., 2020, 104, 104269.
41. Karan Kumar, B., Faheem, Chandra Sekhar, K.V.G, Adinarayana, N., Murugesan, S. Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An update. Heliyon, 2020, 6, e04916.
40. Srinivasarao, S., Adinarayana, N., Suresh, A., Agnieszka, E., Agnieszka, G., Balaram, G., Karankumar, B., Murugesan, S., Sravani, P., Himanshu A., Chandra Sekhar, K.V.G*. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents. Bioorg. Chem., 2020, 100, 103955.
39. Srinivasarao, S., Adinarayana, N., Suresh, A., Kevin Van C, Linda De V, Davie C., Balaram, G., Himanshu A., Murugesan, S., Chandra Sekhar, K.V.G*. Seeking potent anti-tubercular agents: design and synthesis of substituted-N-(6-(4-(pyrazine-2-carbonyl)piperazine/homopiperazine-1-yl)pyridin-3-yl)benzamide derivatives as anti-tubercular agents. RSC Adv., 2020, 10, 12272-12288.
38. Srinivasarao, S., Adinarayana, N., Shashidhar, N., Tsz, T.Y., Sravani, P., Balaram, G., Murugesan, S., Naresh, K., Chandra Sekhar, K.V.G*. Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent Quorum Sensing in Pseudomonas aeruginosa. RSC Adv., 2019, 9, 29273-29292.
37. Surendar, C., Srinivasarao, S., Santosh, P.K.R., Prakruti, T., Yamini, B., Chandan, K., Krishnan, R., Balaram, G., Chandra Sekhar, K.V.G*. Design, synthesis and biological evaluation of 2-(3,4-dimethoxyphenyl)-6-(1,2,3,6-tetrahydropyridin-4-yl)imidazo[1,2-a]pyridine analogues as antiproliferative agents. Bioorg. Med. Chem. Lett., 2019, 29, 2551-2558.
36. Suresh, N., Surendar, C., Suresh, A., Sridhar, G., Mallika, A., Debanjan, B., Nishant, J., Chandra Sekhar, K.V.G*. Design, Synthesis, and Biological Evaluation of 2-(4-Aminophenyl) benzothiazole Analogues as Antiproliferative Agents, J. Het. Chem, 2019, 56, 520-532.
35. Arun kumar, T., Ratnakaram V. N., Srinivasu, N., Yamini, B., Balaram, G., Chandra Sekhar, K.V.G*., Design, synthesis and anti-tumour activity of new pyrimidine-pyrrole appended triazoles. Toxicol. In Vitro, 2019, 60, 87–96.
34. Mahalakshmi Naidu, K., Rudresh Naik, G., Chandra Sekhar, K.V.G.* Design, synthesis and biological evaluation of 5-(2-(4-(substitutedbenzo[d]isoxazol-3-yl)piperazin-1-yl)acetyl)indolin-2-one and 5-(2-(4-substituted piperazin-1-yl)acetyl)indolin-2-one analogues as novel anti-tubercular agents. Arab. J. Chem. 2019, 12, 2418-2429.
33. Nagesh, H.N., Srinivasarao, S., Suresh, A., Nizalapur, S., Murugesan, S., Kanneboina, K., Kumar, N., Chandra Sekhar, K.V.G*. Sulfur-Assisted Deprotection of Methylene Nitrile Group: One-Pot Synthesis of 4-Substituted-2H-1,2,3-triazoles. Chemistry Select, 2018, 3, 7565-7571.
32. Chander, S., Ashok, P., Reguera, R., Perez, M., Andres, R., Rafael, B., Chandra Sekhar, K.V.G., Murugesan, S. Synthesis and activity of benzopiperidine, benzopyridine and phenyl piperazine based compounds against Leishmania infantum. Exp. Parasitol., 2018, 189, 49-60.
31. Srinivasarao, S., Nizalapur, S., Yu T T., Wenholz, D.S., Trivedi, P., Ghosh, B., Rangan, K., Kumar, N., Chandra Sekhar, K.V.G*. Design, Synthesis and Biological Evaluation of Triazole-Containing 2-Phenylindole and Salicylic Acid as Quorum Sensing Inhibitors against Pseudomonas aeruginosa, Chemistry Select, 2018, 3, 9170-9180.
30. Suresh N., Suresh A., Suresh Y., Manikapal, B., Mallika, A., Chandra Sekhar, K.V.G*. Anti-proliferative activity, molecular modeling studies and interaction with calf thymus DNA of novel ciprofloxacin analogues. J Chem. Sci., 2018, 130, 121.
29. Suresh, A., Srinivasarao, S., Agnieszka, Ewa, Mallika, A., Lherbet, C, Chandra Sekhar, K.V.G*. Design, synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors. Chem. Biol. Drug Des. 2017, 91, 1078-1086.
28. Suresh, N, Chitti S, Suresh, A, Bhattacharjee D, Rao BB, Jain N, Alvala M, Chandra Sekhar, K.V.G*. Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors. Bioorg. Med. Chem. Lett., 2017, 27, 3794-3801.
27. Lindemann, M., Deuther-Conrad, W., Moldovan, R., Brust, P., Wenzel, B., Chandra Sekhar, K.V.G., Do spiroindolines have the potential to replace vesamicol as lead compound for the development of radioligands targeting the vesicular acetylcholine transporter? Bioorg. Med. Chem. 2017, 25, 5107-5113.
26. Suresh, A., Mahalakshmi Naidu K., Srinivasarao, S., Agnieszka,N., Ewa, AK., Misra, S., Murugesan, S., Chander, S., Krishnan, R., Chandra Sekhar, K.V.G*. Identification and development of pyrazolo[4,3-c]-pyridine carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors. New J. Chem., 2017, 41, 347-357.
25. Mahalakshmi Naidu K., Srinivasarao, S., Agnieszka,N., Ewa, A-K., Chandra Sekhar, K.V.G*., Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives. Bioorg. Med. Chem. Lett. 2016, 26, 2245-2250.
24. Suresh, N., Surendar, C., Bhaskara Rao, B., Mallika, A., Nishant J., Chandra Sekhar, K. V. G*., Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA. Eur. J. Med. Chem. 2016, 114, 220-231.
23. Suresh, A., Suresh, N., Misra, S., Krishna Kumar, M.M., Chandra Sekhar, K.V.G*., Design, Synthesis and Biological Evaluation of New Substituted Sulfonamide Tetrazole Derivatives as Antitubercular Agents. Chemistry Select, 2016, 1, 1705-1710.
22. Nagesh, H.N., Suresh, A., Reddy, M.N., Suresh, N., Subbalakshmi, J., Chandra Sekhar, K.V.G*., Multicomponent cascade reaction: dual role of copper in the synthesis of 1,2,3-triazole tethered benzimidazo[1,2-a]quinoline and their photophysical studies. RSC Adv., 2016, 6, 15884-15894.
21. Goh, W., Gardner, C. R., Chandra Sekhar, K.V.G., Biswas, N. N., Shashidhar, N., Rice, S.C., Willcox, M., Black, D. S., Kumar, N., Synthesis, quorum sensing inhibition and docking studies of 1,5-dihydropyrrol-2-ones. Bioorg. Med. Chem., 23, 7366-7377, 2015.
20. Mahalakshmi Naidu, K., Nagesh, H.N., Singh, M., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G*., Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors. Eur. J. Med. Chem. 2015, 92, 415-426.
19. Nagesh, H.N., Suresh, N., Bhanu Prakash, G.V.S., Gupta, S., Rao, J.V., Chandra Sekhar, K.V.G* Design, synthesis and biological evaluation of novel phenanthridinyl piperazine triazoles via click chemistry as anticancer agents. Med. Chem. Res. 2015, 24, 523-532.
18. Mahalakshmi Naidu, K., Suresh, A., Subbalakshmi, J., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G*
Raghavaiah, P. Design, synthesis and antimycobacterial activity of various 3-(4-substituted sulfonylpiperazin-1-yl)benzo[d]isoxazole derivatives. Eur. J. Med. Chem. 2014, 87, 71-78.
17. Nagesh, H.N., Suresh, A., Sairam, S.D.S.S., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G.* Design, synthesis and antimycobacterial evaluation of 1-(4-(2-substitutedthiazol-4-yl)phenethyl)-4-(3-(4-substitutedpiperazin-1-yl)alkyl)piperazine hybrid analogues. Eur. J. Med. Chem. 2014, 84, 605-613.
16. Nagesh, H.N., Suresh, N., Mahalakshmi Naidu, K., Arun, B., Sridevi, J.P., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G*. Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues. Eur. J. Med. Chem. 2014, 74, 333-339.
15. Suresh, N., Nagesh, H.N., Renuka, J., Rajput, V., Sharma, R., Khan, I.A., Chandra Sekhar, K.V.G*. Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl) piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents. Eur. J. Med. Chem. 2014, 71, 324-332.
14. Suresh, N., Nagesh, H.N., Anil Kumar, Shirazi, A.N., Parang, K., Chandra Sekhar, K.V.G*. Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines. Bioorg. Med. Chem. Lett. 2013, 23 (23), 6292-6295.
13. Nagesh, H.N., Mahalakshmi Naidu, K., Harika Rao, D., Sridevi, J.P., Sriram, D., Yogeeswari, P., Chandra Sekhar, K.V.G*. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1yl) phenanthridine analogues as antimycobacterial agents. Bioorg. Med. Chem. Lett. 2013, 23 (24), 6805-6810.
12. Chandra Sekhar, K.V.G*., Rao V.S., Conrad W. D., Nagesh, H. N., Sreedhar Kumar, V., Divya Sridhar., Brust P., Murali Krishna M., Synthesis, Preliminary in vitro and in vivo pharmacological evaluation of4-{4-[2-(4-(2-substitutedquinoxalin-3-yl)piperazin-1-yl]ethyl) phenyl}thiazoles as atypical antipsychotic agents. Med. Chem. Res. 2013, 22 (4), 1660-1673.
11. Chandra Sekhar, K.V.G*., Rao. V.S., Tara Sasank, T. V. N. V., Nagesh, H.N., Suresh, N, Mahalakshmi Naidu, K., Suresh, A., Synthesis of 3,5-diarylisoxazoles under solvent-free conditions using iodobenzene diacetate. Chin. Chem. Lett. 2013, 24 (12), 1045 -1048.
10. Chandra Sekhar, K.V.G*., Vyas, D. R. K., H N Nagesh, Rao. V.S., Pharmacophore Hypothesis for Atypical Antipsychotics. Bull. Korean Chem. Soc. 2012, 33 (9), 2930-2936.
9. Chandra Sekhar, K.V.G*., Rao V.S., Kumar, D., Synthesis of Triazolo Quinoxalines as Antitubercular Agents. Bull. Korean Chem. Soc. 2011, 32 (8), 2657-2660.
8. Chandra Sekhar, K.V.G*., Rao V.S., Conrad W. D., Satish Reddy A., Brust P., Murali Krishna M. Design, Synthesis and Preliminary in vitro and in vivo pharmacological evaluation of 2-{4-[4-(Substituted thiazolyl)phenylethyl] piperazin-1-yl}-1,8-naphthyridine-3-carbonitriles as atypical antipsychotic agents. J. Enzyme Inhib. Med. Chem., 2011, 26 (4), 561-568.
7. Chandra Sekhar, K.V.G*., Rao V.S., Satish Reddy, A., Sunandini, R., Kumar Satuluri, V.S.A., Solvent Free Microwave Accelerated Synthesis of Heterocyclic Thiazolidin-4-ones as Antimicrobial and Antifungal Agents. Bull. Korean Chem. Soc. 2010, 31 (5), 1219-1222.
6. Chandra Sekhar, K.V.G*., Rao V.S., Murali Krishna Kumar M., Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents. J. Enzyme Inhib. Med. Chem., 2009, 24(3), 871-875.
5. Chandra Sekhar, K.V.G*., Rao V.S., Ravi Kumar Vyas, D., Murali Krishna Kumar M., Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents. Bioorg. Med. Chem. Lett., 2008, 18, 6054-6057.
4. Rao, V.S., Chandra Sekhar K.V.G*., Iodobenzene diacetate mediated solid-state synthesis of Heterocyclyl 1,3,4-oxadiazoles. Synthetic Commun., 2004, Vol.34 (12): 2153-2157.
3. Kumar, D., Chandra Sekhar, K.V.G., Dhillon, H., Rao, V.S., Varma, R.S., An expeditious synthesis of 1-aryl-4-methyl-1,2,4-triazolo [4,3-a] quinoxalines under solvent-free conditions using iodobenzene diacetate. Green Chem., 2004, Vol. 3: 156-157.
2. Sriram, D., Rao, V.S., Chandra Sekhar, K.V.G., Yogeeswari, P. Progress in the Research of Artemisinin and its analogues as antimalarials: An Update, Nat. Prod Res., 2004, Vol.18 (6): 503-527.
1. Rashmi P., Shaw A.K., Bhaduri A.P., Chandra Sekhar K. V. G., Anil S., Kishore K. S., Vineeta C., Ranjana S., Brahm S. S., Shalini A., Sudhir S., Higher Acyclic Nitrogen containing Deoxy sugar derivatives: A new lead in the generation of antimycobacterial chemotherapeutics. Bioorg. Med. Chem. Lett., 2002, 10, 1695-1702.